RxSight, Inc.: cashflow_investing
| Value | {"amount": -14859000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-03-31 |
| Status | current |
| Entity | RxSight, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:09:18.754153+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f34afae5-257f-4d7d-b4a3-1a7d1ee1bf33
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-019703Retrieved: 2026-08-19T11:09:18.754153+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001111485/cashflow-investing/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f34afae5-257f-4d7d-b4a3-1a7d1ee1bf33
History
- supersedes {"amount": 14859000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} (evidence 0000950170-22-007878)